Oral leukoplakias (OL) are common whitish patches of the oral cavity having a well-documented potential risk of malignant transformation [1–3]. The prevalence of OL is approximately 1% in all ages, the annual rate of malignant transformation of untreated lesions having been reported as 2–3% [1]. Meanwhile, the risk of recurrence after the surgical treatment of non-homogeneous leukoplakia has been estimated at up to 20%, and oral squamous cell carcinomas (OSCC) developed from OL demonstrate poor clinical outcomes [2].
http://ift.tt/2jIO7S8
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου